Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Krystal

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 22, 2001
Mechanisms of resistance to imatinib (STI571) and prospects for combination with conventional chemotherapeutic agentsG W Krystal
Biochimica Et Biophysica Acta|March 1, 1997
Identification of novel human tumor cell-specific CaMK-II variantsR M Tombes, G W Krystal
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1992
Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-mycB C Armstrong, G W Krystal
Cancer Research|June 1, 1997
Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostinsG W Krystal, P Carlson, J Litz
Oncogene|October 24, 2000
A novel assay for the measurement of Raf-1 kinase activityC Bondzi, S Grant, G W Krystal
Molecular and Cellular Biology|August 1, 1990
N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcriptsG W Krystal, B C Armstrong, J F Battey
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 26, 2000
Src family kinase activity is required for Kit-mediated mitogen-activated protein (MAP) kinase activation, however loss of functional retinoblastoma protein makes MAP kinase activation unnecessary for growth of small cell lung cancer cellsC Bondzi, J Litz, P Dent, et al.
Cancer Research|January 15, 1996
Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factorG W Krystal, S J Hines, C P Organ
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growthG W Krystal, S Honsawek, J Litz, et al.
Blood|December 3, 1998
Selective Sp1 binding is critical for maximal activity of the human c-kit promoterG H Park, H K Plummer, G W Krystal
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 22, 2001
Mechanisms of resistance to imatinib (STI571) and prospects for combination with conventional chemotherapeutic agentsG W Krystal
Biochimica Et Biophysica Acta|March 1, 1997
Identification of novel human tumor cell-specific CaMK-II variantsR M Tombes, G W Krystal
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1992
Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-mycB C Armstrong, G W Krystal
Cancer Research|June 1, 1997
Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostinsG W Krystal, P Carlson, J Litz
Oncogene|October 24, 2000
A novel assay for the measurement of Raf-1 kinase activityC Bondzi, S Grant, G W Krystal
Molecular and Cellular Biology|August 1, 1990
N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcriptsG W Krystal, B C Armstrong, J F Battey
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 26, 2000
Src family kinase activity is required for Kit-mediated mitogen-activated protein (MAP) kinase activation, however loss of functional retinoblastoma protein makes MAP kinase activation unnecessary for growth of small cell lung cancer cellsC Bondzi, J Litz, P Dent, et al.
Cancer Research|January 15, 1996
Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factorG W Krystal, S J Hines, C P Organ
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growthG W Krystal, S Honsawek, J Litz, et al.
Blood|December 3, 1998
Selective Sp1 binding is critical for maximal activity of the human c-kit promoterG H Park, H K Plummer, G W Krystal
Pageof 2